A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain (RemivsDex)
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Ohio
-
Cleveland, Ohio, Vereinigte Staaten, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, Vereinigte Staaten, 44195
- The Cleveland Clinic Foundation
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
Patients who undergo general anesthesia for elective surgical excision of a brain tumor with following specifications:
- Age: Older than 18
- Primary and redo cases will be included
- Duration of surgery not exceeding 6 hrs.
Exclusion Criteria:
- Patient refusal
- Emergency craniotomy
- Morbid obesity
- Uncontrolled hypertension - DBP more than 110
- Cardiac conduction defects
- Patients with chronic pain.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Aktiver Komparator: Remifentanil
Remifentanil 0.08-0.15MCG/KG/MIN
INFUSION THROUGHOUT PROCEDURE BASED ON HEMODYNAMICS
|
Remifentanil 0.08-0.15MCG/KG/MIN
INFUSION THROUGHOUT PROCEDURE BASED ON HEMODYNAMICS
Andere Namen:
|
|
Aktiver Komparator: Dexmedetomidine
a loading dose of dexmedetomidine was given at 0.5 to 1 micrograms/kg ideal body weight over 15 minutes, followed by an infusion at 0.2 to 0.7 micrograms/kg/hour.
|
a loading dose of dexmedetomidine was given at 0.5 to 1 micrograms/kg ideal body weight over 15 minutes, followed by an infusion at 0.2 to 0.7 micrograms/kg/hour.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Hemodynamics
Zeitfenster: 15, 30, 45, 60, and 90 minutes after extubation.
|
Hemodynamics were defined as mean arterial pressure (MAP), measured in milimeters of mercury (mmHg).
This outcome was analyzed using a repeated measures ANOVA approach.
In the outcome measure data table, mean ± standard deviation MAP was reported as the aggregate mean across time points.
|
15, 30, 45, 60, and 90 minutes after extubation.
|
|
Postoperative Pain
Zeitfenster: 15, 30, 45, 60, and 90 minutes after extubation.
|
Pain was measured using the visual analogue scale (VAS), where 0 is defined as no pain and 10 is defined as worst pain imaginable.
This outcome was analyzed using a repeated measures ANOVA approach.
In the outcome measure data table, mean ± standard deviation pain was reported as the aggregate mean across time points.
|
15, 30, 45, 60, and 90 minutes after extubation.
|
|
Total Opioid Consumption
Zeitfenster: Initial 90 minutes of recover after surgery
|
Total opioid consumption was defined as the sum of all opioid doses given within the first 90 minutes after surgery, converted to milligram morphine equivalents.
|
Initial 90 minutes of recover after surgery
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Heart Rate
Zeitfenster: 15, 30, 45, 60, and 90 minutes after extubation.
|
Heart rate was determined from the arterial catheter and measured as beats per minute.
This outcome was analyzed using a repeated measures ANOVA approach.
|
15, 30, 45, 60, and 90 minutes after extubation.
|
|
Modified Short Orientation Memory Concentration Test (SOMCT)
Zeitfenster: 15, 30, 45, 60, and 90 minutes after extubation.
|
The Modified Short Orientation Memory Concentration Test (SOMCT) is a validated questionnaire that discriminates among mild, moderate, and severe cognitive deficits.
SOMCT is based on 6 questions and produces a total score ranging from 0 (worst possible function) to 28 (best possible function).
Scores > 20 are considered normal.
This outcome was analyzed using a repeated measures ANOVA approach.
|
15, 30, 45, 60, and 90 minutes after extubation.
|
|
Aldrete Score
Zeitfenster: 15, 30, 45, 60, and 90 minutes after extubation.
|
The Aldrete score measured level of sedation and fitness and is used to assess the appropriate departure time from the post anesthesia care unit.
The score ranges from 0 to 10, where 0 indicates poor fitness (and such patients are transferred to the ICU), while 10 indicates good fitness.
This outcome was analyzed using a repeated measures ANOVA approach.
|
15, 30, 45, 60, and 90 minutes after extubation.
|
|
Nursing Workload Comparison
Zeitfenster: 90 minutes after extubation
|
To evaluate the nurses workload when either of the two drugs are given in terms Nursing Research Usage form's therapeutic index scoring system.
This score ranges from 0 (minimal interventions and time spent by nurses on study patient) to 22 (maximum interventions and time spent by nurses on the study patient).
|
90 minutes after extubation
|
|
Drug Stop Time to Open Eyes
Zeitfenster: Anesthesia drug stop time to open eyes. Time is measured continuously until patients eyes open, regardless of how long it takes.
|
time until patient first opened their eyes, squeezed a hand, or wiggled their toes in response to verbal commands after surgery
|
Anesthesia drug stop time to open eyes. Time is measured continuously until patients eyes open, regardless of how long it takes.
|
|
Drug Stop Time to Recall
Zeitfenster: Time between extubation until patients could say their names.
|
Time between extubation until patients could say their names.
|
Time between extubation until patients could say their names.
|
|
Drug Stop Time to Fitness to Discharge
Zeitfenster: Anesthesia drug stop time to fitness to discharge. Time is measured continuously until fitness for discharge is reached, regardless of how long it takes.
|
Anesthesia drug stop time to fitness to discharge. Time is measured continuously until fitness for discharge is reached, regardless of how long it takes.
|
|
|
End Case to Post Anesthesia Care Unit (PACU) Discharge
Zeitfenster: End case to post anesthesia care unit (PACU) discharge. Time is measured continuously until PACU discharge, regardless of how long it takes.
|
Post Anesthesia Care Unit (PACU) Discharge time is the timing at which patients are discharged from the PACU.
This outcome is the amount of time (minutes) from end case to PACU discharge.
|
End case to post anesthesia care unit (PACU) discharge. Time is measured continuously until PACU discharge, regardless of how long it takes.
|
|
Postoperative Nausea
Zeitfenster: Whether patients had nausea or not, from anesthesia stop time until hospital discharge.
|
Indicator of whether patients had nausea or not
|
Whether patients had nausea or not, from anesthesia stop time until hospital discharge.
|
|
Postoperative Vomitting
Zeitfenster: Whether patients had vomiting or not, from anesthesia stop time until hospital discharge.
|
Indicator of whether patients had postoperative vomiting.
|
Whether patients had vomiting or not, from anesthesia stop time until hospital discharge.
|
|
Postoperative Shivering
Zeitfenster: Whether patients had postoperative or not, from anesthesia stop time until hospital discharge.
|
Indicator of whether patients had postoperative shivering.
|
Whether patients had postoperative or not, from anesthesia stop time until hospital discharge.
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Ermittler
Ermittler
- Hauptermittler: Shobana Rajan, MD, The Cleveland Clinic
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Studienbeginn
Primärer Abschluss (Tatsächlich)
Primärer Abschluss
Studienabschluss (Tatsächlich)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Pathologische Prozesse
- Postoperative Komplikationen
- Schmerzen
- Neurologische Manifestationen
- Schmerzen, postoperativ
- Physiologische Wirkungen von Arzneimitteln
- Adrenerge Wirkstoffe
- Neurotransmitter-Agenten
- Molekulare Mechanismen der pharmakologischen Wirkung
- Depressiva des zentralen Nervensystems
- Agenten des peripheren Nervensystems
- Analgetika
- Agenten des sensorischen Systems
- Analgetika, nicht narkotisch
- Adrenerge Alpha-2-Rezeptor-Agonisten
- Adrenerge Alpha-Agonisten
- Adrenerge Agonisten
- Analgetika, Opioide
- Betäubungsmittel
- Hypnotika und Beruhigungsmittel
- Remifentanil
- Dexmedetomidin
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- 10-1056
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .